Cases 31 - 40 of 1,745
BREZDENIUK v. Boehringer Ingelheim Corp. et al
as 9:2023cv80058
Plaintiff:
RICHARD BREZDENIUK
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee:
MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
ANDERSON v. GLAXOSMITHKLINE INC. et al
as 9:2023cv80052
Plaintiff:
RUSSELL ANDERSON
Defendant:
GLAXOSMITHKLINE INC., GlaxoSmithKline LLC, Ajanta Pharma USA Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2023cv00877
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ANDERSON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv13680
Plaintiff:
JERRY ANDERSON and PHILISA J. ANDERSON
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KENNEDY v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv13282
Plaintiff:
ROBERT KENNEDY
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff:
JAMES WOJNICKI
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Pfizer Inc. et al v. Aurobindo Pharma Limited et al
as 1:2023cv00717
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma, Inc. v. Sandoz Inc.
as 23-2032
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
SANDOZ INC., PRINSTON PHARMACEUTICAL INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
